NM_006059.4:c.1865C>G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_006059.4(LAMC3):c.1865C>G(p.Pro622Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000855 in 1,613,912 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P622H) has been classified as Uncertain significance.
Frequency
Consequence
NM_006059.4 missense
Scores
Clinical Significance
Conservation
Publications
- occipital pachygyria and polymicrogyriaInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, Illumina
- complex neurodevelopmental disorderInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006059.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMC3 | NM_006059.4 | MANE Select | c.1865C>G | p.Pro622Arg | missense | Exon 11 of 28 | NP_006050.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMC3 | ENST00000361069.9 | TSL:2 MANE Select | c.1865C>G | p.Pro622Arg | missense | Exon 11 of 28 | ENSP00000354360.4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152208Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000156 AC: 39AN: 250782 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.0000889 AC: 130AN: 1461704Hom.: 1 Cov.: 33 AF XY: 0.0000825 AC XY: 60AN XY: 727148 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
LAMC3: BP4, BS2
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 622 of the LAMC3 protein (p.Pro622Arg). This variant is present in population databases (rs142041428, gnomAD 0.04%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with LAMC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 435736). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.1865C>G (p.P622R) alteration is located in exon 11 (coding exon 11) of the LAMC3 gene. This alteration results from a C to G substitution at nucleotide position 1865, causing the proline (P) at amino acid position 622 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at